Noisy respiratory secretions at the end of life

Current Opinion in Supportive and Palliative Care

Volumn 3, Issue 2, 2009, Pages 120-124

  Clark, Katherine ^a,c   Butler, Michelle ^b  

^a UNIVERSITY OF NOTRE DAME   (Australia)

^b Sacred Heart Palliative Centre   (Australia)

^c Sacred Heart Centre   (Australia)

Author keywords

Communication; Death rattles; Noisy secretions; Terminal care

Indexed keywords

ABNORMAL RESPIRATORY SOUND; ARTICLE; CONSCIOUSNESS DISORDER; DYSPNEA; HUMAN; NOISE; PATHOPHYSIOLOGY; SECRETIONS; TERMINAL CARE;

BODILY SECRETIONS; CONSCIOUSNESS DISORDERS; DYSPNEA; HUMANS; NOISE; RESPIRATORY SOUNDS; TERMINAL CARE;

EID: 67651238494     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e32832af251     Document Type: Article

References (32)

1. Wildiers H, Menten J. Death rattle: prevalence, prevention and treatment. J Pain Symptom Manage 2002;23:310-317.
2. Ellershaw JE, Sutcliffe JM, Saunders CM. Dehydration and the dying patient. J Pain Symptom Manage 1995;10:192-197.
3. Wee B, Hillier R. Interventions for noisy breathing in patients near to death. Cochrane Database Syst Rev 2008:CD005177. This study provides a succulent summary of the problem and systematically reviews evidence that underpins the use of anticholinergic medications for 'death rattles'.
4. Wee BL, Coleman PG, Hillier R, Holgate SH. The sound of death rattle II: how do relatives interpret the sound? Palliat Med 2006;20:177-181.
5. Bennett MI. Death rattle: an audit of hyoscine (scopolamine) use and review of management. J Pain Symptom Manage 1996;12:229-233.
6. Wildiers H, Demeulenaere P, Clement P, Menten J. Treatment of death rattle in dying patients. Belgian J Med Oncol 2008;2:275-279. A preliminary report of a large prospective study examining three anticholinergic medications for the 'death rattle'.
7. Morita T, Tsunoda J, Inoue S, Chihara S. Risk factors for death rattle in terminally ill cancer patients: a prospective exploratory study. Palliat Med 2000;14:19-23.
8. van der Schans CP. Bronchial mucus transport. Respir Care 2007;52: 1150-1158.
9. Restrepo RD. Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance? Respir Care 2007;52:1159-1173; discussion 73-75.
10. Morita T, Hyodo I, Yoshimi T, et al. Incidence and underlying etiologies of bronchial secretion in terminally ill cancer patients: a multicenter, prospective, observational study. J Pain Symptom Manage 2004;27:533-539.
11. Seah STA, Low JA, Chan YH. Symptoms and care of dying elderly patients in an acute hospital. Singapore Med J 2005;46:210-214.
12. Glare P, Clark K. Management of a patient with terminal illness: the final stages of life. Med Today 2008;9:40-48.
13. Elman LB, Dubin RM, Kelley M, McCluskey L. Management of oropharyngeal and tracheobronchial secretions in patients with neurologic disease. J Palliat Med 2005;8:1150-1159.
14. Sorenson HM. Managing secretions in dying patients. Respir Care 2000;45:1355-1363; discussion 63-64.
15. Rubin BK. Physiology of airway mucus clearance. Respir Care 2002;47:761-768.
16. Hidaka N, Nagao K. Bronchioloalveolar carcinoma accompanied by severe bronchorrhea. Chest 1996;110:281-282.
17. Brambrink AM, Tzanova I. Neurogenic pulmonary oedema after generalized epileptic seizure. Eur J Emerg Med 1998;5:59-66.
18. Dammers R, van den Bent MJ. Neurogenic pulmonary oedema in a patient with leptomeningeal carcinomatosis. J Neurol Neurosurg Psychiatry 2006;77:1097.
19. Macmillan CSA, Grant IS, Andrews PJD. Pulmonary and cardiac sequelae of subarachnoid haemorrhage: time for active management? Intensive Care Med 2002;28:1012-1023.
20. Macleod AD. Neurogenic pulmonary edema in palliative care. J Pain Symptom Manage 2002;23:154-156.
21. Windsor J, Dewdney A, Crooks R, Grocott M. Postobstructive pulmonary oedema. Hosp Med 2004;65:508.
22. Ellershaw J, Ward C. Care of the dying patient: the last hours or days of life. BMJ 2003;326:30-34.
23. Back IN, Jenkins K, Blower A, Beckhelling J. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle. Palliat Med 2001;15:329-336.
24. Clark K, Currow D, Agar M, et al. A pilot phase II randomized, cross-over, double-blinded, controlled efficacy study of octreotide versus hyoscine hydrobromide for control of noisy breathing at the end-of-life. J Pain Palliat Care Pharmacother 2008;22:131-138.
25. Hughes AC, Wilcock A, Corcoran R. Management of 'death rattle'. J Pain Symptom Manage 1996;12:271-272.
26. Wee BL, Coleman PG, Hillier R, Holgate SH. The sound of death rattle I: are relatives distressed by hearing this sound? Palliat Med 2006;20:171-175.
27. Lanuke K, Fainsinger RL, DeMoissac D. Hydration management at the end of life. J Palliat Med 2004;7:257-263.
28. Kanto J, Watanabe H, Namiki A. Pharmacological premedication for anaesthesia. Acta Anaesthesiol Scand 1996;40:982-990.
29. Twycross R, Wilcox A. Symptom management in advanced cancer. 3rd ed. Oxford: Oxford Radcliffe Medical Press; 2001.
30. Spruyt O, Kausae A. Antibiotic use for infective terminal respiratory secretions. J Pain Symptom Manage 1998;15:263-264.
31. van der Steen JT, Ooms ME, van der Wal G, Ribbe MW. Pneumonia: the demented patient's best friend? Discomfort after starting or withholding antibiotic treatment. J Am Geriatr Soc 2002;50:1681-1688.
32. Rothaar R, Epstein S. Extubation failure: magnitude of the problem, impact on outcomes, and prevention. Curr Opin Crit Care 2003;9: 59-66.